Benjamin Garcia-Bloj
Overview
Explore the profile of Benjamin Garcia-Bloj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcelain K, Selman-Bravo C, Garcia-Bloj B, Bustamante E, Fernandez J, Gaete F, et al.
Rev Med Chil
. 2024 Aug;
151(10):1344-1360.
PMID: 39093138
Cancer will remain one of the most significant challenges for public health, locally and globally. Currently, cancer is the leading cause of death in our country. Thanks to the enormous...
2.
Munoz-Medel M, Pinto M, Goralsky L, Caceres M, Villarroel-Espindola F, Manque P, et al.
Front Oncol
. 2024 May;
14:1403089.
PMID: 38807771
() is a gram-negative oral pathogen associated with chronic periodontitis. Previous studies have linked poor oral health and periodontitis with oral cancer. Severe cases of periodontal disease can result in...
3.
Owen G, Cordova-Delgado M, Bustos B, Cerpa L, Gonzalez P, Morales-Pison S, et al.
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675222
Background: Pharmacogenomic knowledge as a biomarker for cancer care has transformed clinical practice, however, as current guidelines are primarily derived from Eurocentric populations, this limits their application in Latin America,...
4.
Pinto M, Munoz-Medel M, Retamal I, Bravo M, Latapiat V, Cordova-Delgado M, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613445
Recently, the combination of chemotherapy plus nivolumab (chemo-immunotherapy) has become the standard of care for advanced-stage gastric cancer (GC) patients. However, despite its efficacy, up to 40% of patients do...
5.
Cordova-Delgado M, Pinto M, Pizarro G, Koch E, Vargas C, Hernandez M, et al.
J Gastrointest Oncol
. 2022 Sep;
13(4):2057-2064.
PMID: 36092312
Background: Early-onset gastric cancers (EOGC) are poor prognosis hard-to treat malignancies that affect young individuals (<45 years old). Case Description: Herein we describe the case of a 26-year-old female EOGC...
6.
Rios J, Marcelain K, Plaza-Parrochia F, Selman C, Bustamante E, Godoy J, et al.
Rev Med Chil
. 2022 Jun;
149(11):1657-1663.
PMID: 35735330
With or without a COVID19 pandemic, cancer is and will continue to be one of the greatest health challenges on the planet. In Chile, during 2016, this disease was the...
7.
Cordova-Delgado M, Pinto M, Regonesi C, Cereceda L, Reyes J, Itriago L, et al.
J Pers Med
. 2022 Feb;
12(2).
PMID: 35207683
Major advances in sequencing technologies and targeted therapies have accelerated the incorporation of oncology into the era of precision medicine and "biomarker-driven" treatments. However, the impact of this approach on...
8.
Moses C, Nugent F, Waryah C, Garcia-Bloj B, Harvey A, Blancafort P
Mol Ther Nucleic Acids
. 2019 Jan;
14:287-300.
PMID: 30654190
PTEN expression is lost in many cancers, and even small changes in PTEN activity affect susceptibility and prognosis in a range of highly aggressive malignancies, such as melanoma and triple-negative...
9.
Moses C, Garcia-Bloj B, Harvey A, Blancafort P
Eur J Cancer
. 2018 Feb;
93:10-18.
PMID: 29433054
The hallmarks of cancer were proposed as a logical framework to guide research efforts that aim to understand the molecular mechanisms and derive treatments for this highly complex disease. Recent...
10.
Kretzmann J, Ho D, Evans C, Plani-Lam J, Garcia-Bloj B, Mohamed A, et al.
Chem Sci
. 2017 Apr;
8(4):2923-2930.
PMID: 28451358
Tools for editing the genome and epigenome have revolutionised the field of molecular biology and represent a new frontier in targeted therapeutic intervention. Although efficiencies and specificities of genome editing...